GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qualis Innovations Inc (OTCPK:QLIS) » Definitions » EV-to-EBITDA

Qualis Innovations (Qualis Innovations) EV-to-EBITDA : -28.94 (As of May. 16, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Qualis Innovations EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Qualis Innovations's enterprise value is $5.38 Mil. Qualis Innovations's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.19 Mil. Therefore, Qualis Innovations's EV-to-EBITDA for today is -28.94.

The historical rank and industry rank for Qualis Innovations's EV-to-EBITDA or its related term are showing as below:

QLIS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -28.94   Med: 24.61   Max: 27.13
Current: -28.94

During the past 9 years, the highest EV-to-EBITDA of Qualis Innovations was 27.13. The lowest was -28.94. And the median was 24.61.

QLIS's EV-to-EBITDA is ranked worse than
100% of 486 companies
in the Medical Devices & Instruments industry
Industry Median: 16.29 vs QLIS: -28.94

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Qualis Innovations's stock price is $0.263. Qualis Innovations's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.083. Therefore, Qualis Innovations's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Qualis Innovations EV-to-EBITDA Historical Data

The historical data trend for Qualis Innovations's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qualis Innovations EV-to-EBITDA Chart

Qualis Innovations Annual Data
Trend Jul06 Jul07 Jul08 Jul09 Jul10 Dec11 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -3.22 6.15 -8.20 -12.26 -13.73

Qualis Innovations Quarterly Data
Jul10 Oct10 Jan11 Apr11 Sep11 Dec11 Mar12 Jun12 Sep12 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.26 -12.42 -2.56 -3.04 -13.73

Competitive Comparison of Qualis Innovations's EV-to-EBITDA

For the Medical Devices subindustry, Qualis Innovations's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qualis Innovations's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qualis Innovations's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Qualis Innovations's EV-to-EBITDA falls into.



Qualis Innovations EV-to-EBITDA Calculation

Qualis Innovations's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5.382/-0.186
=-28.94

Qualis Innovations's current Enterprise Value is $5.38 Mil.
Qualis Innovations's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qualis Innovations  (OTCPK:QLIS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Qualis Innovations's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.263/-0.083
=At Loss

Qualis Innovations's share price for today is $0.263.
Qualis Innovations's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.083.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Qualis Innovations EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Qualis Innovations's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Qualis Innovations (Qualis Innovations) Business Description

Traded in Other Exchanges
N/A
Address
225 Wilmington West Chester Pike, Suite 200, No.145, Chadds Ford, PA, USA, 19317
Qualis Innovations Inc. is the holding company of mPathix Health, Inc. The company is focused on the development, production, and distribution of multi-modal pain management and Central Nervous System related solutions. It develops pain management products using a modality agnostic, virtual operating model. The company is developing a product designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their current treatment regimen.
Executives
Bin Wang director 112 RICO DR. NORTH, MORGANVILLE NJ 07751